Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03971136
Other study ID # ECHO-STA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 4, 2019
Est. completion date July 1, 2023

Study information

Verified date February 2023
Source Centre Hospitalier Intercommunal Creteil
Contact Camille JUNG, MD, PhD
Phone +3357022268
Email camille.jung@chicreteil.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

ATS (acute thoracic syndrome) refers to acute pulmonary involvement in a sickle cell patient. The diagnosis is based on the association of clinical signs (fever or respiratory symptoms) with a recent pulmonary infiltrate on the chest x-ray. The main objective of the study is to evaluate the place of the pulmonary ultrasound for the diagnosis of ATS, in comparison with frontal chest x-ray.


Description:

The ATS occurs in half of the cases during hospitalization for a VOC (Vaso Occlusive crisis). The morbidity of ATS is important (respiratory insufficiency, duration of hospitalization, stays in intensive care, brain complications, pain, hypoxia, long-term sequelae, etc.) but no study has shown the benefits of curative treatments such as transfusion ( recommended at the time of diagnosis and practiced by some teams) or noninvasive ventilation (practiced by other teams). The first step before studying curative treatments is to have tools for early detection of ATS. Recent studies show non-inferiority of pulmonary ultrasonography compared to radiography and thoracic computed tomography in the diagnosis of pulmonary condensation (in adults and children). In a study performed in sickle cell adults admitted for ATS, pulmonary ultrasound was more sensitive than X-ray in detecting images of pulmonary consolidations visible on the chest CT scan. Daswani et al have also shown the value of pulmonary ultrasound in comparison with radiography in the detection of consolidation lesions, suggestive of STA, in febrile children or young adults with sickle cell disease. They showed a good sensitivity (87%) and specificity (94%) of the pulmonary ultrasound.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date July 1, 2023
Est. primary completion date April 30, 2023
Accepts healthy volunteers No
Gender All
Age group 12 Months to 17 Years
Eligibility Inclusion Criteria: - Age: =12 months and <18 years - Has a major sickle cell disease whatever the genotype - Admission to hospital for a febrile vaso-occlusive crisis (VOC) or not - Evolving at home for less than 48h - Concomitant treatment with hydroxycarbamide / hydroxyurea possible - Signed consent - Patients affiliated to a French social security scheme Exclusion Criteria: - Child presenting an acute thoracic syndrome (ATS) from the outset at the admission - Child who presented an ATS in the month preceding the inclusion - Child in regular transfusion program or child who has received a hematopoietic stem cell transplant - Child hospitalized at least 5 times for VOC in the year preceding inclusion (psychic problems making difficult the evaluation of the pain) - Child who has already been included in the study during a previous VOC (each child participates in the study only once) - VOC evolving for more than 48 hours before admission to the emergency room - Acute splenic sequestration crisis at admission

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
pulmonary ultrasound
The subjects will have an ultrasound on admission and on day 1, 2 and 3

Locations

Country Name City State
France Hôpital Antoine Béclère Clamart
France Centre Hospitalier Intercommunal Créteil Créteil
France Hôpital Bicêtre Le Kremlin-Bicêtre
France Hôpital Armand Trousseau Paris

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal Creteil

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity of pulmonary ultrasound Proportion of subjects with positive pulmonary ultrasound among those with a positive chest X-ray at time t with 95% confidence interval at day 1 Day 1
Primary Sensitivity of pulmonary ultrasound Proportion of subjects with positive pulmonary ultrasound among those with a positive chest X-ray at time t with 95% confidence interval at day 2 Day 2
Primary Sensitivity of pulmonary ultrasound Proportion of subjects with positive pulmonary ultrasound among those with a positive chest X-ray at time t with 95% confidence interval at day 3 Day 3
Secondary Specificity of pulmonary ultrasound Proportion of subjects with a positive pulmonary ultrasound among those with a negative chest X-ray at time t at day 1 Day 1
Secondary Specificity of pulmonary ultrasound Proportion of subjects with a positive pulmonary ultrasound among those with a negative chest X-ray at time t at day 2 Day 2
Secondary Specificity of pulmonary ultrasound Proportion of subjects with a positive pulmonary ultrasound among those with a negative chest X-ray at time t at day 3 Day 3
Secondary Sensitivity of pulmonary ultrasound in relation with ATS diagnosis Proportion of subjects with positive pulmonary ultrasound among those with a positive chest X-ray at time t with 95% confidence intervalat day -3 of ATS diagnosis day -3 of ATS diagnosis
Secondary Sensitivity of pulmonary ultrasound in relation with ATS diagnosis Proportion of subjects with positive pulmonary ultrasound among those with a positive chest X-ray at time t with 95% confidence interval at day -1 of ATS diagnosis day -1 of ATS diagnosis
Secondary Sensitivity of pulmonary ultrasound in relation with ATS diagnosis Proportion of subjects with positive pulmonary ultrasound among those with a positive chest X-ray at time t with 95% confidence interval at day -2 of ATS diagnosis day -2 of ATS diagnosis
Secondary Specificity of pulmonary ultrasound in relation with ATS diagnosis Proportion of subjects with a positive pulmonary ultrasound among those with a negative chest X-ray at time t at day -1 of ATS diagnosis day -1 of ATS diagnosis
Secondary Specificity of pulmonary ultrasound in relation with ATS diagnosis Proportion of subjects with a positive pulmonary ultrasound among those with a negative chest X-ray at time t at day -3 of ATS diagnosis -3 day of ATS diagnosis
Secondary Specificity of pulmonary ultrasound in relation with ATS diagnosis Proportion of subjects with a positive pulmonary ultrasound among those with a negative chest X-ray at time t at day -2 of ATS diagnosis day -2 of ATS diagnosis